Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
1.120
-0.020 (-1.75%)
At close: Apr 23, 2026, 4:00 PM EDT
1.390
+0.270 (24.10%)
After-hours: Apr 23, 2026, 7:59 PM EDT
Tivic Health Systems Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
52
Market Cap
3.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
| Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
| Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nuwellis | 8.27M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Intelligent Bio Solutions | 3.58M |
| Catheter Precision | 819.00K |
| Co-Diagnostics | 622.49K |
| iTonic Holdings | 523.03K |
| Profusa | 75.00K |
TIVC News
- 5 hours ago - Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model - PRNewsWire
- 8 days ago - Tivic Health Selected to Present Entolimod™ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th - PRNewsWire
- 23 days ago - Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - Accesswire
- 27 days ago - Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - Accesswire
- 4 weeks ago - Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome - Accesswire
- 4 weeks ago - Tivic Reports Full Year 2025 Results - Accesswire
- 4 weeks ago - Tivic Health CEO Letter to Shareholders - Accesswire
- 4 weeks ago - Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET - Accesswire